A multinational, drug utilization study to investigate the use of dexmedetomidine (Dexdor®) in clinical practice in the EU.
Mary WeatherallRiku AantaaGiorgio ContiChris GarrattPasi PohjanjousiMichael A LewisNicholas MooreSusana Perez-GutthannPublished in: British journal of clinical pharmacology (2017)
Overall, most patients were treated with dexmedetomidine according to the product labelling. Use in children was limited but significant and similar in scope to that in adults. Administrations not fully according to the product labelling usually occurred in an ICU environment and reflected extensively investigated clinical uses of dexmedetomidine.
Keyphrases
- clinical practice
- end stage renal disease
- cardiac surgery
- newly diagnosed
- ejection fraction
- chronic kidney disease
- intensive care unit
- multidrug resistant
- peritoneal dialysis
- prognostic factors
- young adults
- emergency department
- acute kidney injury
- patient reported outcomes
- mechanical ventilation
- atomic force microscopy
- extracorporeal membrane oxygenation